(Q47914796)

6 February 2018

title

Prevention of murine cerebral malaria by low-dose cyclosporin A. (English)

1 reference

6 February 2018

0 references

0 references

1 reference

Grau GE

1

1 reference

6 February 2018

Gretener D

series ordinal

2

1 reference

6 February 2018

Lambert PH

series ordinal

3

1 reference

6 February 2018

publication date

1 August 1987

1 reference

6 February 2018

published in

Immunology

1 reference

6 February 2018

volume

61

1 reference

6 February 2018

page(s)

521-525

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei.

cites work

1 reference

12 December 2020

L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.

1 reference

12 December 2020

Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes

1 reference

12 December 2020

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

12 December 2020

The effect of antithymocyte serum on golden hamsters and rats infected with Plasmodium berghei

1 reference

12 December 2020

Brain Capillary Blockage Produced by a Virulent Strain of Rodent Malaria

1 reference

12 December 2020

Cerebral malaria. On the nature and significance of vascular changes.

1 reference

12 December 2020

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

12 December 2020

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

1 reference

12 December 2020

The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts

1 reference

12 December 2020

IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides

1 reference

12 December 2020

Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells.

1 reference

12 December 2020

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

12 December 2020

Antimalarial activity of cyclosporin A.

1 reference

12 December 2020

Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice.

1 reference

12 December 2020

Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro

1 reference

12 December 2020

Studies on the transcapillary escape rate of fibrinogen and capillary permeability in patients with Plasmodium falciparum malaria.

1 reference

12 December 2020

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

1 reference

12 December 2020

Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A

1 reference

12 December 2020

Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes.

1 reference

12 December 2020

Cell-mediated immunity in nutritional deficiency.

1 reference

12 December 2020

Cyclosporin a inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion

1 reference

12 December 2020

Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration

1 reference

12 December 2020

The effects of cyclosporin A on the immune system

1 reference

12 December 2020

Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia

1 reference

12 December 2020

Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s)

1 reference

12 December 2020

Identifiers

PubMed ID

3327806

1 reference

6 February 2018